NYU CLINICAL CANCER CENTER

What NYU CLINICAL CANCER CENTER does

The Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, also known as NYU Clinical Cancer Center, is an NCI-designated Comprehensive Cancer Center — the highest designation awarded by the National Cancer Institute — providing state-of-the-art, research-based cancer care across all cancer types. It operates as a nonprofit academic medical center component, affiliated with NYU Grossman School of Medicine, and serves adult and pediatric cancer patients across the New York metropolitan area. The center's portfolio includes a comprehensive Perlmutter Cancer Center service line, an expansive clinical trials program, the Stephen D. Hassenfeld Children's Center for Cancer and Blood Disorders for pediatric oncology, and a broad set of cancer support services spanning integrative health, nutrition, oncology rehabilitation, social work, supportive care, survivorship, cardio-oncology, and tobacco cessation, complemented by prevention, screening, research, and education/training programs.

The business is supported by three primary revenue streams: patient care services delivered across inpatient and outpatient settings; NCI Cancer Center Support Grant (CCSG) funding and other research grants supporting research programs, shared resources, and multidisciplinary disease groups; and philanthropy, including named funds such as the Dana and Albert R. Broccoli Cancer Research Fund. Care is distributed through a multi-borough footprint spanning Manhattan, Brooklyn, Queens, Long Island, and Staten Island (the latter opened May 2026), with patient acquisition driven by physician referrals, self-referral, and community outreach. Technology infrastructure centers on the MyChart patient portal and the NYU Langone Health mobile app for records access, scheduling, and care-team communication, augmented by a vendor-supported AI-powered website chat feature.

Go-to-market is sales-led and reputation-driven, leveraging earned media, digital and social channels (website, Facebook, Twitter/X, YouTube, Instagram), community partnerships (e.g., Stamp Out Cancer Brooklyn, Project HEATWAVE), and a referral network of primary care physicians and specialists across the NYU Langone ecosystem. Pricing is not publicly disclosed, consistent with the complexity of academic medical center billing, with revenue generated per service rendered and reimbursed through insurance, grants, and charitable contributions rather than a transactional SaaS-style pricing model.

Name

NYU CLINICAL CANCER CENTER

Legal name

NYU Langone Health

Website

https://nyuci.org

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

NYU Clinical Cancer Center is the NCI-designated Comprehensive Cancer Center at NYU Langone Health, providing research-based cancer diagnosis, treatment, clinical trials, and support services across Manhattan, Brooklyn, Queens, Long Island, and Staten Island.

Ownership category

akta.pro rank

Product category

Comprehensive Cancer Care

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Ambulatory Health Care Services (621), Offices of Physicians (62111)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG)

Keywords

• Cancer treatment
• Clinical oncology
• Cancer research
• Pediatric oncology
• Oncology clinical trials

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Care Services: Revenue generated from comprehensive cancer treatment services including diagnostics, treatment, surgery, chemotherapy, radiation therapy, and follow-up care provided to patients.
2. Research Grants and Funding: NCI Cancer Center Support Grant (CCSG) funding and other research grants supporting cancer research programs, member research, shared resources, and multidisciplinary disease groups.
3. Philanthropy and Donations: Donations and charitable contributions designated for the Perlmutter Cancer Center, including the Dana and Albert R. Broccoli Cancer Research Fund.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

NCI-designated Comprehensive Cancer Center providing state-of-the-art, research-based cancer care across all cancer types. Operates multiple outpatient locations throughout Manhattan, Brooklyn, Queens, Long Island, and Staten Island, delivering diagnosis, surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, clinical trials, survivorship care, and supportive services. Integrated within NYU Langone Health for multidisciplinary care across medical specialties.

Product overview

The Laura and Isaac Perlmutter Cancer Center at NYU Langone Health is an NCI-designated Comprehensive Cancer Center offering a unified suite of cancer care services. The core offering is the Perlmutter Cancer Center itself, which provides research-based approaches for all cancer types through locations in Manhattan, Brooklyn, Queens, and Long Island. The portfolio includes an expansive clinical trials program, specialized pediatric care through the Hassenfeld Children's Center, and comprehensive support services (integrative health, nutrition, rehabilitation, social work, survivorship, cardio-oncology, and tobacco cessation). Prevention and screening programs, research programs, and education/training initiatives complement the clinical services. Patients access care through the center directly, supported by MyChart patient portal and the NYU Langone Health mobile app.

Differentiator

Problem solved

Functional benefit

Products and services

• Perlmutter Cancer Center NCI-designated Comprehensive Cancer Center providing state-of-the-art, research-based cancer care across all cancer types with locations throughout Manhattan, Brooklyn, Queens, Long Island, and Staten Island.
• Clinical Trials Expansive portfolio of clinical trials ensuring patients receive the most advanced care possible across all cancer types.
• Stephen D. Hassenfeld Children's Center for Cancer and Blood Disorders Specialized pediatric oncology services for children with cancer and blood disorders.
• Cancer Support Services Comprehensive support including integrative health, nutrition services, oncology rehabilitation, social work services, supportive care, survivorship program, cardio-oncology program, and tobacco cessation.
• Cancer Prevention & Screening Programs focused on cancer prevention and early detection through screening services.

Quantifiable outcome

• NCI-designated Comprehensive Cancer Center providing research-based approaches for all types of cancer

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Partnerships

Two partnerships are on record, tiered minor.

• Project HEATWAVEminorStrategic or Co-development Partner · 26 September 2024Initiative to minimize deaths from extreme heat amid rising global temperatures. First initiative of its kind focused on heat-related health impacts.
• Stamp Out Cancer BrooklynminorStrategic or Co-development PartnerCommunity partnership initiative aimed at reducing the overall burden of cancer in Brooklyn through collaboration with community stakeholders, education, screening programs, and outreach efforts.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Fred Hutchinson Cancer Center: NCI-designated Comprehensive Cancer Center in Seattle with strong translational research, clinical trials, and academic affiliation to UW Medicine — comparable as an elite research-driven cancer program.
• Johns Hopkins Sidney Kimmel Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center at Johns Hopkins, comparable as an elite-tier academic cancer program with parallel research, trial, and multidisciplinary care capabilities.
• Dana-Farber Cancer Institute: NCI-designated Comprehensive Cancer Center affiliated with Harvard, offering parallel research, clinical trials, and multidisciplinary oncology care as a non-geographic direct peer at the same elite tier.
• Roswell Park Comprehensive Cancer Center: America's first NCI-designated Comprehensive Cancer Center, a freestanding specialty hospital and research institute operating outside the NYC metro — comparable as an elite NCI Comprehensive peer but in a different geographic market.
• MD Anderson Cancer Center: The largest NCI-designated Comprehensive Cancer Center globally; competes for high-acuity and destination-program patients nationally and internationally with overlapping research and clinical trial capabilities.

Direct peers

• Memorial Sloan Kettering Cancer Center: The largest and most prestigious NCI-designated Comprehensive Cancer Center in the NYC metro, competing head-to-head for the same patient pool with a similar portfolio of multidisciplinary oncology care, clinical trials, and research programs.
• Herbert Irving Comprehensive Cancer Center (Columbia): NCI-designated Comprehensive Cancer Center at Columbia/NewYork-Presbyterian, competing for the same academic-affiliated patient population with parallel research, trial, and clinical capabilities.
• Tisch Cancer Institute at Mount Sinai: NCI-designated cancer center at Mount Sinai Health System serving Manhattan and the broader NYC metro with comparable clinical, research, and trial offerings anchored to an academic medical center.
• Montefiore Einstein Comprehensive Cancer Center: NCI-designated cancer center serving the Bronx and Westchester with comparable research-based care, clinical trials, and academic affiliation to Einstein School of Medicine.
• Weill Cornell Medicine — Meyer Cancer Center: Joint NCI-designated cancer program between Weill Cornell, NewYork-Presbyterian, and Columbia, offering comparable multidisciplinary oncology care, clinical trials, and research in the same Manhattan market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/nyulangone
• YouTubeyoutube.com/c/NYULangoneHealth
• Facebookfacebook.com/NYULangone
• LinkedInlinkedin.com/company/nyu-clinical-cancer-center
• Instagraminstagram.com/nyulangone

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NYU CLINICAL CANCER CENTER